Highlights and Quick Summary
- Total current assets for the quarter ending June 30, 2023 was $306 Million (a -4.04% decrease compared to previous quarter)
- Year-over-year quarterly Total current assets decreased by -12.18%
- Annual Total current assets for 2022 was $335 Million (a -13.05% decrease from previous year)
- Annual Total current assets for 2021 was $385 Million (a 963.77% increase from previous year)
- Annual Total current assets for 2020 was $36.2 Million (a 40158.89% increase from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current assets of Design Therapeutics, Inc.
Most recent Total current assetsof DSGN including historical data for past 10 years.Interactive Chart of Total current assets of Design Therapeutics, Inc.
Design Therapeutics, Inc. Total current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $306.05 | $318.94 | – | – | – |
| 2022 | $335.12 | $348.49 | $361.72 | $373.87 | $335.12 |
| 2021 | $385.44 | $395.29 | $404.88 | $411.75 | $385.44 |
| 2020 | – | – | – | $36.23 | $36.23 |
| 2019 | – | – | – | – | $0.09 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology